1. J Affect Disord. 2017 Apr 15;213:172-177. doi: 10.1016/j.jad.2017.02.023. Epub
 2017 Feb 16.

The interaction of GSK3B and FXR1 genotypes may influence the mania and 
depression dimensions in mood disorders.

Bureau A(1), Beaulieu JM(2), Paccalet T(3), Chagnon YC(4), Maziade M(4).

Author information:
(1)Centre de recherche de l'Institut universitaire en santé mentale de Québec du 
Centre intégré universitaire en santé et services sociaux de la 
Capitale-Nationale, Québec, Canada; Département de médecine sociale et 
préventive, Université Laval, Québec, Canada. Electronic address: 
alexandre.bureau@msp.ulaval.ca.
(2)Centre de recherche de l'Institut universitaire en santé mentale de Québec du 
Centre intégré universitaire en santé et services sociaux de la 
Capitale-Nationale, Québec, Canada; Département de psychiatrie et neurosciences, 
Université Laval, Québec, Canada; Department of Pharmacology and Toxicology, 
University of Toronto, Toronto, Ontario, Canada.
(3)Centre de recherche de l'Institut universitaire en santé mentale de Québec du 
Centre intégré universitaire en santé et services sociaux de la 
Capitale-Nationale, Québec, Canada.
(4)Centre de recherche de l'Institut universitaire en santé mentale de Québec du 
Centre intégré universitaire en santé et services sociaux de la 
Capitale-Nationale, Québec, Canada; Département de psychiatrie et neurosciences, 
Université Laval, Québec, Canada.

BACKGROUND: Previous evidence in healthy subjects suggested that functional 
polymorphisms GSK3B rs12630592 and FXR1 rs496250 interact in regulating mood and 
emotional processing. We attempted to replicate this interaction primarily on 
manic and depressive dimensions in mood disorder patients, and secondarily on 
schizophrenia patients, diagnosis itself and age of onset.
METHODS: Symptom dimensions were derived from the Comprehensive Assessment of 
Symptoms and History 82 items rated lifetime in acute episodes and stabilized 
interepisode intervals in 384 patients from the Schizophrenia and Bipolar 
Disorder Eastern Quebec Kindred Study. Linear mixed effect models of symptom 
dimensions included rs12630592-rs496250 main and interaction fixed effects 
(obtained from TaqMan genotypes), and a polygenic random effect. The 
distribution of lifetime best-estimate DSM-IV diagnosis of 855 kindred members 
was studied versus genotype under a polytomous logistic model.
RESULTS: In mood disorder patients, the level of mania (in both acute and 
stabilized periods) and depression in stabilized periods was positively 
associated with GSK3B rs12630592 T only in FXR1 rs496250 A-allele carriers 
(Bonferroni-corrected interaction p=0.024, 0.052 and 0.017 respectively). The 
two polymorphisms explained 11% of mania variance and 5% of interepisode 
depression variance. The association was observed neither in schizophrenia 
patients nor with the psychotic dimension in mood disorder patients. Interaction 
with the diagnosis distribution (p=0.03) was driven by the decreasing prevalence 
of recurrent major depression with rs12630592 T also only in carriers of 
rs496250 A.
LIMITATIONS: Sample size was limited, but power was sufficient to detect the 
tested interaction effect in this replication sample.
CONCLUSIONS: We replicate in affective patients an interaction between the FXR1 
rs496250 and GSK3B rs12630592 polymorphisms in regulating mood dimensions.

Copyright © 2017 Elsevier B.V. All rights reserved.

DOI: 10.1016/j.jad.2017.02.023
PMID: 28242499 [Indexed for MEDLINE]